Skip to main content

Moderna’s Covid-19 Vaccine Is More Than 94% Effective, Preliminary Data Shows

Published 1 year ago
By Forbes

TOPLINE: Moderna’s Covid-19 vaccine is 94.5% effective in preventing the disease, preliminary data from large-scale phase three trials shows, the company announced in a press release on Monday.


The preliminary data is based on an evaluation of 95 confirmed Covid-19 infections among the trial’s 30,000 participants.

According to the company, 90 of the participants who got infected with Covid-19 are from the placebo group while only 5 cases of infection were seen in the group that received two doses of the vaccine.

This is a developing story. Check back for updates.

-By Siladitya Ray, Forbes Staff

Sign Up for Our Newsletter Daily Update

Get the best of Forbes Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.
Related Topics: #Breaking News, #Coronavirus, #Coronavirus deaths, #Coronavirus Outbreak, #Coronavirus Pandemic, #Coronavirus Payment, #Coronavirus tracking app, #Coronavirus Vaccine, #COVID-19, #Covid-19 Deaths.